Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for ProPhase Labs (PRPH) over the last 11 years, with Q3 2025 value amounting to $185000.0.

  • ProPhase Labs' Gains from Investment Securities changed N/A to $185000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 470000.0%. This contributed to the annual value of $3.8 million for FY2024, which is 3487.69% down from last year.
  • Per ProPhase Labs' latest filing, its Gains from Investment Securities stood at $185000.0 for Q3 2025.
  • Over the past 5 years, ProPhase Labs' Gains from Investment Securities peaked at $6.0 million during Q4 2022, and registered a low of -$392000.0 during Q4 2023.
  • Over the past 5 years, ProPhase Labs' median Gains from Investment Securities value was $290000.0 (recorded in 2021), while the average stood at $1.7 million.
  • Per our database at Business Quant, ProPhase Labs' Gains from Investment Securities tumbled by 26666.67% in 2021 and then soared by 4637272.73% in 2022.
  • Quarter analysis of 5 years shows ProPhase Labs' Gains from Investment Securities stood at $290000.0 in 2021, then skyrocketed by 1968.97% to $6.0 million in 2022, then plummeted by 106.53% to -$392000.0 in 2023, then surged by 845.66% to $2.9 million in 2024, then tumbled by 93.67% to $185000.0 in 2025.
  • Its Gains from Investment Securities stands at $185000.0 for Q3 2025, versus $40000.0 for Q2 2025 and $256000.0 for Q1 2025.